Oxycodon-Hcl Akut Zentiva

Active Ingredient:: Oxycodone Hydrochloride
Origin:: EU

Oxycodon-Hcl Akut Zentiva (Oxycodone Hydrochloride)

International sale not permitted. Listed for the domestic market and B2B only.

Oxycodone Hydrochloride, the active ingredient in Oxycodon-Hcl Akut Zentiva, is an opioid analgesic presented as a strength/form for oral use. It is employed in the management of moderate to severe pain, particularly when other analgesics are insufficient, and is prescribed for adult patients.

GNH India supplies Oxycodon-Hcl Akut Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Manufacturer / TM Owner

Zentiva Pharma Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for:

Acute postoperative pain: Provides effective analgesia following surgical procedures.
Cancer‑related pain: Helps manage moderate to severe pain associated with malignancies.
Severe traumatic injury pain: Alleviates intense pain resulting from major injuries.
Chronic non‑cancer pain: May be used when other treatments have failed, under strict medical supervision.

How It Works

Oxycodone Hydrochloride binds selectively to μ‑opioid receptors in the central nervous system, mimicking endogenous opioids. This receptor activation inhibits adenylate cyclase activity, reduces neuronal excitability, and decreases the transmission of nociceptive signals, resulting in analgesia.

Side Effects

Oxycodone Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

Constipation: Reduced gastrointestinal motility leading to hard stools.
Nausea: Sensation of queasiness, sometimes accompanied by vomiting.
Drowsiness: Feeling unusually sleepy or fatigued.
Dry mouth: Decreased salivary flow causing oral dryness.
Dizziness: Light‑headed feeling, especially when standing quickly.
Itching: Mild skin pruritus without rash.

Serious or Rare Side Effects

Respiratory depression: Markedly slowed breathing that can be life‑threatening.
Severe hypotension: Dangerous drop in blood pressure.
Opioid use disorder: Development of dependence or addiction.
Seizures: Uncontrolled electrical activity in the brain.
Anaphylaxis: Acute allergic reaction with airway compromise.
adrenal Cortisol

Precautions & Warnings

When prescribing Oxycodone Hydrochloride, clinicians should consider several safety measures.

Assess pain severity: Confirm that opioid therapy is appropriate for the level of pain.
Evaluate patient history: Review prior opioid use, substance abuse, and respiratory conditions.
Monitor for sedation: Observe for excessive drowsiness or impaired cognition.
Adjust for renal/hepatic impairment: Dose may need modification in organ dysfunction.
Educate on dependence risk: Counsel patients on signs of misuse and safe storage.
Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Oxycodone Hydrochloride can interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

Benzodiazepines: Combined use can cause profound respiratory depression.
CNS depressants: Alcohol, barbiturates, or other sedatives increase sedation and overdose risk.
MAO inhibitors: May precipitate severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

CYP3A4 inhibitors (e.g., ketoconazole): Can raise oxycodone plasma levels.
CYP3A4 inducers (e.g., rifampicin): May reduce analgesic effect.
Anticholinergics: May exacerbate constipation.
Diuretics: Potential for increased hypotension.
Antidepressants (SSRIs/SNRIs): May heighten serotonin‑related effects.

Frequently Asked Questions

Oxycodon-Hcl Akut Zentiva contains oxycodone hydrochloride, an opioid analgesic prescribed for moderate to severe pain. It is commonly used in acute postoperative settings, cancer‑related pain, and severe traumatic injuries where other analgesics are insufficient.

Oxycodone hydrochloride acts as an agonist at μ‑opioid receptors in the central nervous system. By activating these receptors, it inhibits the release of neurotransmitters involved in pain signaling, reduces neuronal excitability, and ultimately diminishes the perception of pain.

The specific dose of Oxycodon-Hcl Akut Zentiva is determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, and overall health status. Dosage adjustments are made to balance effective pain relief with safety considerations.

Oxycodone use during pregnancy and lactation is generally discouraged because it may affect fetal development and can be excreted in breast milk. Healthcare providers should evaluate risks versus benefits and consider alternative pain management strategies when possible.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and necessary import documentation.

Oxycodone hydrochloride offers potent analgesia comparable to morphine but with a slightly higher oral bioavailability. Compared with weaker opioids such as codeine, it provides stronger pain control, though it also carries a higher risk of dependence and respiratory depression, necessitating careful monitoring.

Store the product at or below 25 °C in its original packaging, protecting it from moisture, heat, and direct sunlight. Ensure the container is tightly closed to maintain stability and prevent accidental ingestion.

The medication is intended for oral administration, typically as a tablet or capsule taken with water. Patients should follow the prescribing clinician’s instructions regarding timing, food intake, and any necessary dose adjustments.

The most critical risks include respiratory depression, severe hypotension, opioid dependence or addiction, and rare but life‑threatening reactions such as anaphylaxis. Immediate medical attention is required if signs of respiratory compromise or severe allergic response occur.

Patients with known hypersensitivity to oxycodone or any component of the formulation, those with severe respiratory insufficiency, uncontrolled asthma, or significant head injury should avoid this medication. It is also contraindicated in individuals taking monoamine oxidase inhibitors within 14 days.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 10 Oct 2026

Disclaimer

International sale not permitted. Listed for the domestic market and B2B only.

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.